The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global COVID-19 sample collection kits market is currently experiencing moderate growth. COVID-19 sample collection kits refer to in-vitro diagnostic medical equipment utilized for collecting biological specimens for detecting the SARS-CoV-2 virus. It is a vital step in the effective diagnosis of an active infection of the novel coronavirus in the body. Various health organizations, such as the Centers for Disease Control and Prevention (CDC) and the United States Food and Drug Administration (USFDA), have introduced standard procedures and guidelines for manufacturers to develop COVID-19 sample collection and transport kits that are compatible with the recommended configurations. With the rising number of hospitals expanding their testing capabilities, the demand for COVID-19 collection sample kits is escalating across the globe.
The global COVID-19 sample collection kits market is primarily driven by the growing geriatric population and the increasing number of people suffering from chronic diseases who are more prone to COVID-19 infections. Besides this, governments of several countries are undertaking various initiatives to provide sample collection kits to the masses at an affordable price. The extensive research and development (R&D) activities by the manufacturers in collaboration with the regional authorities and suppliers are also propelling the market growth. For instance, the introduction of a 3D printed nasal swab prototype for commercial use by researchers at the University of South Florida Health has positively impacted the market growth. Furthermore, the availability of swabs in various configurations for the advanced detection of infections has also led to increased adoption of COVID-19 sample collection kits across multiple healthcare centers and hospitals. Looking forward, IMARC Group expects the global COVID-19 sample collection kits market to grow at a CAGR of around 4% during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 sample collection kits market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and site of collection.
Breakup by Product:
Breakup by Application:
Breakup by Site of Collection:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, COPAN Diagnostics, Formlabs, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., Medline Industries Inc., Puritan Medical Products, Thermo Fisher Scientific Inc. and VIRCELL S.L.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at